Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors

INTRODUCTION: Altered epigenetic map is frequently observed in cancer and recent investigations have demonstrated a pertinent role of epigenetic modifications in the response to many anticancer drugs including the DNA damaging agents. Topoisomerase I (Top I) is a well-known nuclear enzyme that is cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Madkour, Moustafa M., Ramadan, Wafaa S., Saleh, Ekram, El-Awady, Raafat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128461/
https://www.ncbi.nlm.nih.gov/pubmed/37092854
http://dx.doi.org/10.1080/07853890.2023.2203946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128461/
https://www.ncbi.nlm.nih.gov/pubmed/37092854
http://dx.doi.org/10.1080/07853890.2023.2203946

Ejemplares similares